Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Moodys
Baxter
Dow
Johnson and Johnson

Last Updated: June 27, 2022

Drug Price Trends for BIMATOPROST


✉ Email this page to a colleague

« Back to Dashboard

Drug Price Trends for BIMATOPROST

Average Pharmacy Cost for BIMATOPROST

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
BIMATOPROST 0.03% EYE DROPS 60505-0583-04 31.03520 ML 2021-06-23
BIMATOPROST 0.03% EYE DROPS 62332-0507-25 31.03520 ML 2021-06-23
BIMATOPROST 0.03% EYE DROPS 70069-0401-01 31.03520 ML 2021-06-23
BIMATOPROST 0.03% EYE DROPS 68180-0429-01 31.03520 ML 2021-06-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for BIMATOPROST

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
LUMIGAN 0.01% OPHTHALMIC SOLUTION Allergan USA, Inc. 00023-3205-05 5ML 384.88 76.97600 ML 2022-01-01 - 2023-09-29 FSS
DURYSTA 10MCG IMPLANT,OPH Allergan USA, Inc. 00023-9652-01 1 1459.66 1459.66000 EACH 2020-06-23 - 2023-09-29 FSS
LUMIGAN 0.01% OPHTHALMIC SOLUTION Allergan USA, Inc. 00023-3205-03 2.5ML 192.51 77.00400 ML 2022-01-01 - 2023-09-29 FSS
LUMIGAN 0.01% OPHTHALMIC SOLUTION Allergan USA, Inc 00023-3205-08 7.5ML 272.41 36.32133 ML 2018-09-30 - 2023-09-29 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Medtronic
Express Scripts
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.